Form D — Amani Therapeutics, Inc.
0002099941-26-000002 · filed Oct 1, 2026
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $59,999,999
- Total sold
- $34,999,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Amani Therapeutics, Inc.
- CIK
- 2099941
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 40 10TH AVENUE
NEW YORK, NY 10014 - Phone
- (646) 597-6980
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alice Lee · Executive OfficerNew York, NY Find on LinkedIn ↗
-
-- RTW Holdings VI, LLC · PromoterNew York, NY Find on LinkedIn ↗
-
Robert Swoboda · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Lauren Cuje · DirectorNew York, NY Find on LinkedIn ↗
-
Peter Fong · DirectorNew York, NY Find on LinkedIn ↗
-
Connor Williams · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗